Agenus Inc (AGEN)
4.97
-0.43
(-7.96%)
USD |
NASDAQ |
Apr 18, 16:00
4.97
0.00 (0.00%)
After-Hours: 07:10
Agenus Free Cash Flow (Quarterly): -40.62M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -40.62M |
| September 30, 2023 | -68.68M |
| June 30, 2023 | -64.48M |
| March 31, 2023 | -60.37M |
| December 31, 2022 | -61.68M |
| September 30, 2022 | -47.91M |
| June 30, 2022 | -61.90M |
| March 31, 2022 | -56.94M |
| December 31, 2021 | -31.89M |
| September 30, 2021 | 108.99M |
| June 30, 2021 | -57.83M |
| March 31, 2021 | -42.94M |
| December 31, 2020 | -36.42M |
| September 30, 2020 | -32.50M |
| June 30, 2020 | -38.49M |
| March 31, 2020 | -35.15M |
| December 31, 2019 | -32.84M |
| September 30, 2019 | -28.62M |
| June 30, 2019 | -36.96M |
| March 31, 2019 | 75.09M |
| December 31, 2018 | -36.41M |
| September 30, 2018 | -25.32M |
| June 30, 2018 | -31.21M |
| March 31, 2018 | -41.75M |
| December 31, 2017 | -26.62M |
| Date | Value |
|---|---|
| September 30, 2017 | -27.11M |
| June 30, 2017 | -28.37M |
| March 31, 2017 | -15.25M |
| December 31, 2016 | -20.44M |
| September 30, 2016 | -28.85M |
| June 30, 2016 | -20.12M |
| March 31, 2016 | -23.07M |
| December 31, 2015 | -20.36M |
| September 30, 2015 | -19.31M |
| June 30, 2015 | -14.07M |
| March 31, 2015 | 2.972M |
| December 31, 2014 | -12.22M |
| September 30, 2014 | -8.441M |
| June 30, 2014 | -10.09M |
| March 31, 2014 | -10.30M |
| December 31, 2013 | -5.611M |
| September 30, 2013 | -4.586M |
| June 30, 2013 | -5.877M |
| March 31, 2013 | -4.273M |
| December 31, 2012 | -3.280M |
| September 30, 2012 | -3.672M |
| June 30, 2012 | -3.411M |
| March 31, 2012 | 11.27M |
| December 31, 2011 | -4.180M |
| September 30, 2011 | -3.403M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-68.68M
Minimum
Sep 2023
108.99M
Maximum
Sep 2021
-38.28M
Average
-40.62M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Protalix BioTherapeutics Inc | 3.345M |
| InfuSystems Holdings Inc | 2.66M |
| PAVmed Inc | -12.06M |
| Allogene Therapeutics Inc | -53.89M |
| Pfizer Inc | 4.196B |